Impact of "Targeted" Nutritional Apport and Exercise on the Modulation of Metabolic and Immune-related Gene Expression Signatures in Early Breast Cancer (eBC) Patients Candidate to Neoadjuvant Therapy (NAT)

NCT06928701 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

160

Enrollment

OTHER

Sponsor class

Conditions

Early Breast Cancer
Neoadjuvant Treatment

Interventions

DIETARY_SUPPLEMENT: omega-3 (n-3 Lc-PUFA), EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) plus a source of palmitoleic acid (hexadecenoic acid)

Sponsor

University of Eastern Piedmont